Zalcitabine (Compound)
Synonyms:zalcitabine, Dideoxycytidine, 7481-89-2, 2',3'-DIDEOXYCYTIDINE, ddCyd, HIVID, Cytidine, 2',3'-dideoxy-, ddC, Zalcitibine, 4-Amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, NSC 606170, Ro 24-2027/000, UNII-6L3XT8CB3I, CHEMBL853, 6L3XT8CB3I, 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one, CHEBI:10101, MFCD00012188, NCGC00090705-08, DSSTox_CID_3747, NSC-606170, 4-AMINO-1-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1,2-DIHYDROPYRIMIDIN-2-ONE, DSSTox_RID_77182, DSSTox_GSID_23747, 2,3-dideoxycytidine, NSC606170, 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one, SMR000058253, CCRIS 692, Hivid(TM), Hivid (TN), HSDB 7156, Interferon AD + ddC, ddC & GM-CSF, ddC & sCD4, PC-SOD & ddC, Ro-24-2027/000, DDC (DDC), BRN 0654956, Zalcitabine (JAN/USP/INN), DS-4152 & ddC, 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine, ddC & NP (from PHCA or HSA), SRI-7707, Zalcitabine [USAN:USP:INN:BAN], CAS-7481-89-2, Zalcitabine- Bio-X, KS-1130, ddC & IFN.alpha., .beta.-D-DDC, dideoxycytidine (DDC), 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one, Prestwick0_001037, Prestwick1_001037, Prestwick2_001037, Prestwick3_001037, ddC & Interferon.alpha., 2', 3'-dideoxycytidine, bmse000712, UPCMLD-DP115, D 5782, SCHEMBL3598, TimTec1_004969, Lopac0_000360, BSPBio_001253, 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine, 5-25-14-00313 (Beilstein Handbook Reference), MLS000069636, MLS000759540, MLS001055363, MLS001424210, MLS006011951, SPBio_003104, BPBio1_001378, GTPL4828, ddC|||2',3'-Dideoxycytidine, DTXSID0023747, UPCMLD-DP115:001, ZINC39906, 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein), AOB5609, HMS1548B19, HMS1571O15, HMS2051H18, HMS2090C12, HMS2098O15, HMS2236N08, HMS3261G21, HMS3715O15, Pharmakon1600-01502360, .beta.-D-2',3'-Dideoxycytidine, Zalcitabine, 2'3'-Dideoxycytidine, BCP13878, Tox21_113491, Tox21_201655, Tox21_303169, Tox21_500360, AC-824, BDBM50145605, Lecithinized superoxide dismutase & .beta.-D-2',3'-Dideoxycytidine
Id:24066
Description:nan
Analyze
CFDE DD-Knowledge Graph
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Zalcitabine's neighborhood in the knowledge graph.
GDLPA Landing Pages Links
The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Zalcitabine.
Playbook Workflow Builder
The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Zalcitabine.
Results found
Linked to
| Label | Description |
|
|---|---|---|---|
 | A Substance | ||
 | Metadatata for zalcitabine | ||
| DrugPage Collection: (DrugCentralID:02856; PubChem_CID:24066, FILE=drugcentral_drug_02856.json) |
Metadatata for zalcitabine
DrugPage Collection: (DrugCentralID:02856; PubChem_CID:24066, FILE=drugcentral_drug_02856.json)
DISPLAY PER PAGE
10
@CFDE Workbench 2026
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
@CFDE Workbench 2026